Skip to main content
Erschienen in: Journal of Nephrology 1/2020

01.02.2020 | Original Article

Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys

verfasst von: Ilaria Girolami, Giovanni Gambaro, Claudio Ghimenton, Serena Beccari, Anna Caliò, Matteo Brunelli, Luca Novelli, Ugo Boggi, Daniela Campani, Gianluigi Zaza, Luigino Boschiero, José Ignacio López, Guido Martignoni, Antonia D’Errico, Dorry Segev, Desley Neil, Albino Eccher

Erschienen in: Journal of Nephrology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Evidence about the reliability of pre-implantation biopsy is still conflicting, depending on both biopsy type and pathologist’s expertise. Aim of the study is to evaluate the agreement of general v specialist pathologists and to compare scores on biopsy and whole organs in a set of discarded kidneys.

Methods

46 discarded kidneys were identified with their corresponding biopsies. The biopsies were reviewed by three general and two specialist pathologists, blinded to the original report, according to Remuzzi score. The intraclass correlation coefficient (ICC) was calculated for both groups. Discarded kidneys were scored according to Remuzzi score by a single specialist pathologist. Biopsies and organs were compared by Wilcoxon signed rank test. Weighted κ coefficients between biopsy and organ scores were also calculated.

Results

Specialist pathologists achieved higher values of ICC, reaching excellent or good agreement in most of the parameters, while general pathologists values were mainly fair or good. On whole organs, scores were consistently lower than biopsies, with a significant difference in most of the parameters. Weighted κ coefficient was slight or fair for most of the parameters.

Conclusions

Our data suggests that the creation of a pool of specialist pathologists would improve organ utilization. Moreover, biopsies are not representative of the whole organ. As the Remuzzi score on biopsy is a major reasons for discard, a quota of transplantable kidneys may be erroneously discarded. Refinement in Remuzzi cut-offs based on expert reporting and recognition of sampling error of biopsies in correlation with clinical outcome data should be undertaken.
Literatur
8.
Zurück zum Zitat Mazzucco G, Magnani C, Fortunato M et al (2010) The reliability of pre-transplant donor renal biopsies (PTDB) in predicting the kidney state. A comparative single-centre study on 154 untransplanted kidneys. Nephrol Dial Transpl 25:3401–3408. https://doi.org/10.1093/ndt/gfq166 CrossRef Mazzucco G, Magnani C, Fortunato M et al (2010) The reliability of pre-transplant donor renal biopsies (PTDB) in predicting the kidney state. A comparative single-centre study on 154 untransplanted kidneys. Nephrol Dial Transpl 25:3401–3408. https://​doi.​org/​10.​1093/​ndt/​gfq166 CrossRef
19.
Zurück zum Zitat Sagasta A, Sánchez-Escuredo A, Oppenheimer F et al (2016) Pre-implantation analysis of kidney biopsies from expanded criteria donors: testing the accuracy of frozen section technique and the adequacy of their assessment by on-call pathologists. Transpl Int 29:234–240. https://doi.org/10.1111/tri.12709 CrossRefPubMed Sagasta A, Sánchez-Escuredo A, Oppenheimer F et al (2016) Pre-implantation analysis of kidney biopsies from expanded criteria donors: testing the accuracy of frozen section technique and the adequacy of their assessment by on-call pathologists. Transpl Int 29:234–240. https://​doi.​org/​10.​1111/​tri.​12709 CrossRefPubMed
21.
Zurück zum Zitat Lester SC (2010) Manual of surgical pathology. Saunders Elsevier, Philadephia Lester SC (2010) Manual of surgical pathology. Saunders Elsevier, Philadephia
23.
Zurück zum Zitat Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420–428CrossRef Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420–428CrossRef
29.
Zurück zum Zitat Furness PN, Taub N, Assmann KJM et al (2003) International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 27:805–810CrossRef Furness PN, Taub N, Assmann KJM et al (2003) International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 27:805–810CrossRef
Metadaten
Titel
Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys
verfasst von
Ilaria Girolami
Giovanni Gambaro
Claudio Ghimenton
Serena Beccari
Anna Caliò
Matteo Brunelli
Luca Novelli
Ugo Boggi
Daniela Campani
Gianluigi Zaza
Luigino Boschiero
José Ignacio López
Guido Martignoni
Antonia D’Errico
Dorry Segev
Desley Neil
Albino Eccher
Publikationsdatum
01.02.2020
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 1/2020
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-019-00638-7

Weitere Artikel der Ausgabe 1/2020

Journal of Nephrology 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.